diaziquone has been researched along with Cancer of Cervix in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ball, H; Blessing, JA; Rettenmaier, M; Slayton, RE | 1 |
| Blessing, JA; Malfetano, J; Slayton, RE; Stehman, FB | 1 |
2 other study(ies) available for diaziquone and Cancer of Cervix
| Article | Year |
|---|---|
A phase II clinical trial of diaziquone (AZQ) in the treatment of patients with recurrent adenocarcinoma and adenosquamous carcinoma of the cervix. A Gynecologic Oncology Group study.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Aziridines; Benzoquinones; Carcinoma, Squamous Cell; Drug Evaluation; Drugs, Investigational; Female; Humans; Middle Aged; Recurrence; Uterine Cervical Neoplasms | 1989 |
Phase II clinical trial of diaziquone in the treatment of patients with recurrent squamous cell carcinoma of the cervix: a Gynecologic Oncology Group Study.
Topics: Adult; Aged; Aziridines; Azirines; Benzoquinones; Carcinoma, Squamous Cell; Drug Evaluation; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Uterine Cervical Neoplasms | 1986 |